FDA’s CDER Is Fostering Use Of Artificial Intelligence In Drug Development

 
• By Brenda Sandburg
  
AI medical
FDA is focusing on use of artificial intelligence and machine learning to enhance drug development • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from AI

More from Advanced Technologies